6525--RFI, Sources Sought Radiopharmaceuticals and Associated Supplies Brand Name or Equal
Special Notice Posted
Not the latest version. See the latest solicitation from .
- Solicitation number
- 36C24624Q0015
- Agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
Notice details come from SAM.gov. Updated .
About this opportunity
This Special Notice from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 modifies a previous request for information regarding radiopharmaceuticals and associated supplies. The notice estimates that at least 75% of the time, standing daily doses of Sestamibi, MDP or HDP bone scans, and Mebrofenin are unused and must be returned for credit by the contractor.
The objective is to seek sources for the provision of these radiopharmaceuticals on a daily basis. Contractors must be able to credit any unused PPO doses of Tc, Sestamibi, Mebro, and HDP. Responses to the modified RFI were due by 1:00 PM Eastern Time on the specified date. The Special Notice clarifies that both HDP and MDP are utilized depending on availability and the clinical situation. Eligible contractors can participate by responding to the RFI with their ability to supply the listed radiopharmaceuticals and credits for unused doses on a daily basis.
Notice text
Modification to a Previous Notice
Modification to a Previous Notice
Page 3 of 3
Modification to a Previous Notice
*= Required Field
Modification to a Previous Notice
Page 1 of 3
Modification #1
RFI 36C24624Q0015 (Radiopharmaceuticals and Associated Supplies)
Question (Black) / Answers (Red)
On 09-20-2023 the following question were received:
Question# 1: One of the requirements is that we credit any unused PPO doses for Tc, Sestamibi, Mebro, and HDP. Â Â Do you have an estimate about how often you order and return unused PPO doses of these products?
Answer #1: We have standing PPO doses of 1 set of Sestamibi, 1 bone dose of either MDP or HDP, and 1 Mebrofenin dose daily. I can only give an estimate of what is returned as I do not have exact numbers at this time. At least 75% of the time these doses are unused and returned.
Question #2: Is there a reason you guys use HDP instead of MDP?
Answer #2: We actually utilize both HDP and MDP dependent on the situation and availability. My understanding is in the past there was availability concerns which lead to both agents being required to be an option.
End of Modification
Files
| File | Type | Posted |
|---|---|---|
| 36C24624Q0015_1.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6525--RFI, Sources Sought Radiopharmaceuticals and Associated Supplies Brand Name or Equal | Solicitation | |
| This notice | Special Notice | |
| 6525--Radiopharmaceuticals Brand Name or Equal | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Sources Sought VISN2 DOWNSTATE GENERAL RADIOPHARMACEUTICALS | Veterans Integrated Service Network 2 | No set-aside | |
| 6505--Radiopharmaceuticals Base Plus Four Option Years VA San Diego Healthcare System | Veterans Integrated Service Network 22 | No set-aside | |
| 6505--General Radioisotopes (Diagnostic & Therapeutic) | Veterans Integrated Service Network 19 | No set-aside | |
| 6505--FY27 Lenalidomide BPA | Veterans Integrated Service Network 22 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity